Previous (2017) Conference Program

  • Learn from industry leaders!

  • BIOtech Japan Keynote Session

    Detail

    BIO-K June 28 (Wed) 12:30-14:30

    Growth Strategy and Future Vision for the Bio Industry
    --Challenges in Medical Care and the Role of Start-ups

    English/Japanese

    Chairman: Ken-ichi Arai, Professor Emeritus, The University of Tokyo/Director, Chairman, SBI Biotech Co., Ltd.

    AMED's Mission --Data Sharing to Fast-track Medical R&D

    Makoto Suematsu
    President,

    Japan Agency for Medical Research and Development (AMED)

    Makoto Suematsu

    A Global and Historical Perspective of Scientific Communication Platforms

    Maoyen Chi
    CEO,

    Cold Spring Harbor Laboratory Asia

    Maoyen Chi

    Development of Innovative Drugs Using Plasmid DNA
    -- Case of Diabetic Peripheral Neuropathy (DPN)

    Sunyoung Kim
    President (R&D),

    ViroMed Co., Ltd. /

    Professor,
    School of Biological Sciences,

    Seoul National University

    Sunyoung Kim

    Biogen's Discovery of Antibody Drug for Alzheimer's Disease and Anti-sense Oligonucleotide (ASO) Agent Development

    Shinichi Torii
    President and Representative Director,

    Biogen Japan Ltd.

    Shinichi Torii

    BIOtech Japan Special Session

    Detail

    BIO-S6 June 30 (Fri) 15:00-16:00FREE〈Pre-registration Required〉

    Tapping Opportunities in China --Based on Our Experience

    English/Japanese

    Thomas Eastling
    Director, Representative Executive Officer, CFO,

    GNI Group Ltd.

    Thomas Eastling

    Yanping Ye
    Executive Director, R&D Dept,

    Shanghai Genomics, Inc./GNI Group Ltd.

    * A new speaker is joining this session. (As of June 23, 2017)

    Yanping Ye
  • <Conference of Concurrent Shows>

  • BioPharma Expo Keynote Session

    Detail

    BP-K June 28 (Wed) 15:30-17:00

    Pharmaceutical and Medical Device Manufacturers
    --R&D Strategies in the New Era

    English/Japanese

    Chairman: Toichi Takenaka, Chairman, Japan Health Sciences Foundation/Program Director, Project for Drug Discovery and Development, Japan Agency for Medical Research and Development(AMED)

    Shionogi's Commitment as a Drug Discovery-type Pharmaceutical Company

    Takuko Sawada
    Director of the Board, Senior Executive Officer,
    Senior Vice President, Corporate Strategy Div.,

    Shionogi & Co., Ltd.

    akuko Sawada

    Medical Device Development Strategy

    Kuniko Shoji
    Director and Corporate Advisor,

    Terumo Corp.

    Kuniko Shoji
  • BioPharma Expo Special Session

    Detail

    BP-S1 June 29 (Thur) 10:00-11:30FREE〈Pre-registration Required〉

    Global Strategies in Biopharma CMOs

    English/Japanese

    Chairman: Kenya Shitara, Executive Officer, Director, Legal and Intellectual Property Dept., Kyowa Hakko Kirin Co., Ltd.

    Delivering for the Patient: Redefining Client Specific Development and Manufacturing Solutions

    Cindy Reiss-Clark
    Sr. Vice President of Global Sales,
    Pharma/Biotech,

    Lonza Ltd.

    Cindy Reiss-Clark

    Flexible Manufacturing --Simplifying Your Outsourcing Strategy

    Kym Baker
    General Manager,

    Patheon

    Kym Baker

    Better CDMO Service by Samsung BioLogics

    TH Kim
    President & CEO,

    Samsung BioLogics Co., Ltd.

    TH Kim

    Detail

    BP-S3 June 30 (Fri) 12:30-14:00FREE〈Pre-registration Required〉

    Advanced IT-based Biologics Drug Discovery --Visual Approach

    English/Japanese

    Chairman: Tatsuhiko Kodama, Professor, Dept. of Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo

    Splicing Snapshots: Cryo-EM Structures of the Spliceosome

    Max Wilkinson

    Medical Research Council Laboratory of Molecular Biology

    Max Wilkinson

    Discovery and Mode of Action of Splicing Inhibitors

    Minoru Yoshida
    Chief Scientist, Chemical Genetics Lab.,

    RIKEN

    Minoru Yoshida

    BioPharma Expo Technical Session

    Detail

    BP-5 June 28 (Wed) 16:30-17:30

    ASME BPE Path Forward in Relation to Future Bioprocessing Trends

    English/Japanese

    Ken Kimbrel
    Chairman Elect

    ASME BPE/

    Vice President,

    UltraClean Electropolish, Inc.

    *Consecutive Interpretation in Japanese.

    Ken Kimbrel
  • INTERPHEX JAPAN Keynote Session

    Detail

    IPJ-K June 28 (Wed) 10:00-11:30

    What is the Key of the Global Growth of the Japanese Pharmaceutical Industry?

    English/Japanese

    Course Leader: Hiroaki Okada, Professor Emeritus, Tokyo University of Pharmacy & Life Sciences

    Sub Leader: Hirofumi Takeuchi, Professor, Dept. of Drug Delivery Technology and Science, Lab. of Pharmaceutical Engineering, Gifu Pharmaceutical University

    Progress of Globalization in the Pharmaceutical Industry and Efforts at Chugai

    Osamu Nagayama
    Chairman of the Board of Directors,
    CEO,

    Chugai Pharmaceutical Co., Ltd.

    Osamu Nagayama

    Addressing the Tension between Manufacturing Innovation/Continuous Improvement & Global Regulatory Divergence

    Roger Nosal
    Vice President, Global Chemistry,
    Manufacturing & Controls,

    Pfizer Inc.

    Nosal Roger
  • INTERPHEX JAPAN Technical Session

    Detail

    IPJ-4 June 29 (Thur) 12:30-14:30

    The Current Status of Continuous Production Facility
    --Case Studies from Manufacturing of Active Pharmaceutical Ingredients

    English/Japanese

    Course Leader: Osamu Matsumoto, Senior Consultant Engineer, Pharmaceutical Engineering Section, Chiyoda Corp.

    Sub Leader: Hitoshi Kitagawa, Senior Executive Officer, Senior General Manager, Infrastructure Div., JGC Corp.

    Transformational Change: How Integrated Continuous Manufacturing Can Revolutionize How We Produce Drugs

    Bayan Takizawa
    Chief Business Officer,

    CONTINUUS Pharmaceuticals, Inc.

    Takizawa Bayan

    Continuous Flow Technology for Development and Manufacturing of APIs in Pharmaceuticals

    Takashi Ouchi
    Principal Researcher,
    Process Chemistry,
    Pharmaceutical Sciences,

    Takeda Pharmaceutical Co., Ltd.

    大内 卓

    Detail

    IPJ-12 June 29 (Thur) 16:00-18:00

    Technologies and State-of-the-art Equipment for Biosimilar Development --Issues and Solutions

    English/Japanese

    Course Leader: Hirofumi Takeuchi, Professor, Dept. of Drug Delivery Technology and Science, Lab. of Pharmaceutical Engineering, Gifu Pharmaceutical University

    Sub Leader: Akiko Koga, Dept. Manager., Production Engineering Dept., Pharmaceutical Technology Div., Chugai Pharmaceutical Co., Ltd.

    Biosimilar --Its Technical Issues in Development and the Solutions--

    Hideaki Nomura
    President & CEO,

    Fujifilm Kyowa Kirin Biologics Co., Ltd.

    Hideaki Nomura

    Leveraging Capacity Solutions to Reduce Time to Market and Maximize NPV

    Brian Taylor
    GM, Life Sciences,

    GE Healthcare

    Brian Taylor
  • Drink JAPAN Keynote Session

    Detail

    DR-K June 29 (Thur) 10:00-11:30

    Things Necessary for the Growth of the Japanese Beverage Industry

    English/Japanese

    Innovation for Growth of the Beverage Industry

    Saburo Kogo
    President & CEO,

    Suntory Beverage & Food Ltd. /

    President,

    Japan Soft Drink Association (JSDA)

    Saburo Kogo



  • (Honorifics omitted) Please note that recording and photography is strictly prohibited. Speakers and programs are subject to change. Textbooks of some presentations might not be available.